First Trust NYSE Arca Biotechnology Index Fund (FBT)
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
$3.61B
Jun 19, 2006
20.20
$8.57
0.00
0.00
1.71%
0.00%
0.00
0.00
0.00
0.00
0.00%
0.00%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (26)
Exact Sciences Corporation
EXAS
4.213%
BeiGene, Ltd.
BGNE
4.037%
Catalyst Pharmaceuticals, Inc.
CPRX
3.833%
Repligen Corporation
RGEN
3.697%
Halozyme Therapeutics, Inc.
HALO
3.681%
Exelixis, Inc.
EXEL
3.66%
Gilead Sciences, Inc.
GILD
3.611%
Illumina, Inc.
ILMN
3.584%
Waters Corporation
WAT
3.513%
United Therapeutics Corporation
UTHR
3.492%
Corcept Therapeutics Incorporated
CORT
3.471%
Natera, Inc.
NTRA
3.376%
Regeneron Pharmaceuticals, Inc.
REGN
3.354%
Mettler-Toledo International Inc.
MTD
3.271%
Bruker Corporation
BRKR
3.236%
BioMarin Pharmaceutical Inc.
BMRN
3.21%
Incyte Corporation
INCY
3.171%
Amgen Inc.
AMGN
3.144%
Alnylam Pharmaceuticals, Inc.
ALNY
3.096%
Vertex Pharmaceuticals Incorporated
VRTX
3.074%
Intra-Cellular Therapies, Inc.
ITCI
2.972%
ACADIA Pharmaceuticals Inc.
ACAD
2.927%
Sarepta Therapeutics, Inc.
SRPT
2.82%
Biogen Inc.
BIIB
2.813%
Neurocrine Biosciences, Inc.
NBIX
2.636%
Moderna, Inc.
MRNA
1.939%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (26)
Exact Sciences Corporation
EXAS
4.213%
BeiGene, Ltd.
BGNE
4.037%
Catalyst Pharmaceuticals, Inc.
CPRX
3.833%
Repligen Corporation
RGEN
3.697%
Halozyme Therapeutics, Inc.
HALO
3.681%
Exelixis, Inc.
EXEL
3.66%
Gilead Sciences, Inc.
GILD
3.611%
Illumina, Inc.
ILMN
3.584%
Waters Corporation
WAT
3.513%
United Therapeutics Corporation
UTHR
3.492%
Corcept Therapeutics Incorporated
CORT
3.471%
Natera, Inc.
NTRA
3.376%
Regeneron Pharmaceuticals, Inc.
REGN
3.354%
Mettler-Toledo International Inc.
MTD
3.271%
Bruker Corporation
BRKR
3.236%
BioMarin Pharmaceutical Inc.
BMRN
3.21%
Incyte Corporation
INCY
3.171%
Amgen Inc.
AMGN
3.144%
Alnylam Pharmaceuticals, Inc.
ALNY
3.096%
Vertex Pharmaceuticals Incorporated
VRTX
3.074%
Intra-Cellular Therapies, Inc.
ITCI
2.972%
ACADIA Pharmaceuticals Inc.
ACAD
2.927%
Sarepta Therapeutics, Inc.
SRPT
2.82%
Biogen Inc.
BIIB
2.813%
Neurocrine Biosciences, Inc.
NBIX
2.636%
Moderna, Inc.
MRNA
1.939%